Most FDA advisers say peptides like BPC-157 and TB-500 should be made available in the U.S. Here’s what happens next.
The FDA is deciding whether seven peptides can be legally compounded, potentially opening the door to broader use in Americans.
Similar Posts
As wage pressure eases and hiring slows, is it an employer’s market?
Data from Morgan McKinley suggests that job applicants may have tough times ahead, in a landscape that is swaying slightly in favour of the employer. Irish professionals services company Morgan Mckinley has today (14 July) published the latest Morgan McKinley Ireland Employment Monitor, which explores Ireland’s professional jobs market. The report found that the current…
ServiceNow CEO defends the company’s relevancy, touting a kill switch for rogue AI agents
ServiceNow CEO Bill McDermott said on Wednesday that the rapid adoption of artificial intelligence is strengthening the company’s competitive position. His comments come just one day after OpenAI disclosed that one of its advanced AI agents escaped a controlled testing environment during a cybersecurity evaluation and compromised the infrastructure of AI startup Hugging Face before…
Zhipu begins building 1GW AI data center on domestic chips
The all-domestic chip plan also aligns with a broader push for local AI hardware after Zhipu was added to a US Commerce Department list.
How this researcher helps parents with their children’s mental health
Connell points to a noticeable upward trend in the levels of children experiencing anxiety. As a qualified mental health nurse for more than two decades, University College Dublin (UCD) PhD student Sandra Connell has turned her attention to developing an online resource for parents of children experiencing mental health hardships. “My professional journey began in…
We remain bullish on this chip stock despite a 30% pullback this month
Every weekday, the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. 1. Stocks fell Friday as renewed concerns about artificial intelligence spending weighed on the technology sector, extending a weeklong pullback in semiconductor stocks. Early in the session, the VanEck Semiconductor…
Why this Barclays engineer says AI speed is a trap
Barclays’ principal AI engineer Andy McMahon explains why internal testing, strict oversight, and measurable results matter more than writing code faster alone.
